stockmonster6 wrote: as someone on the SONA board pointed out, THRM has about the came market cap as SONA.
THRM has about 4 times more outstanding shares than SONA.
Considering they are 4 times our price, that all makes sense. That means, until approval news break we can likely see ourselves floating around these prices in comparison to our competitor SONA.
However, at these low prices, you have much more opportunity to make $$.
Our shares going to $4 would be a similar market cap as when SONA went to $16.
But will THRM go above that $4 mark and beat SONA's higher market cap at $16? That is where I think the potential for THRM is the same. SONA was $0.01 cents before their COVID plays. Could not THRM also have similar results?
$0.50 to $16 is 32 x instead of SONA reaching it's high.
Go THRM!!
You forgot one important factor stockmonster6 wrote:My observation is this:
SONA has had "it's day" in the spotlight, with less information and less progress which shot it to $16. People, including SONA investors are more cautious now.
Therambright is ahead of SONA wrt to the Salvia test.
The potential is, if we max out expectations:
SONA - $2 to $16 (8 times) Shares outstanding ~ 52.2 million.. Market cap = ~$ 98.2 million
THRM - $.50 to $16 (32 times) Shares outstanding ~210.47 million.. Market cap = ~$92.6 million
Now get your calculator back out Einstein.. LOL.. as you've just exposed your level of investment prowess again.. LOL..
With THRM's share price being less than SONA, the potential when FDA and HC news breaks (for either/or, and assuming they have competitive tests) is higher for THRMA.
Given SONA's past issues, and putting the cart before the horse (and the various class actions suits it seems), THRM is a better bet in the short term. I believe SONA is once again going the wrong direction with seeking approvals before any lab tests have been publicized.
Just my take. I'm already heavily invested in THRM. If I had owned any SONA, at this point, the ability to make more $$ and for many, to recover losses, remains higher in THRM.